Intellinetics, Inc. INLX
5.15
0.00
0.00%
as of 25 Sep
- Market cap
- $23.2M
- P/E
- 0.0×
Follow INLX
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
3.06 | 2.07 | 2.01 | 1.52 | |
P/FCF ratio |
64.16 | 312.31 | 0.00 | 0.00 | |
P/Operating CF |
37.50 | (64.78) | (143.29) | 580.04 | |
P/B ratio |
4.43 | 3.02 | 3.13 | 2.50 | |
Price to Tangible BV |
19.34 | 12.77 | 17.41 | 18.93 | |
EV/Sales |
2.88 | 1.92 | 1.89 | 1.42 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
29.74 | 34.17 | 41.98 | 36.06 | |
EV/FCF |
60.25 | 290.36 | (431.91) | (328.63) | |
Quick Ratio |
0.88 | 0.93 | 0.78 | 0.62 | |
Current Ratio |
0.99 | 1.03 | 0.90 | 0.75 | |
Net Debt/EBITDA |
67.78 | (20.63) | 2.29 | 2.06 | |
Debt/Assets |
0.73% | 0.67% | 0.61% | 0.54% | |
Debt/Equity |
0.01 | 0.01 | 0.01 | 0.01 | |
Asset Turnover |
0.89 | 0.92 | 0.94 | 0.99 | |
Operating CF/Net income |
(3.65) | 2.55 | 0.19 | (0.04) | |
Capex/Depreciation |
(0.62) | (0.44) | (0.63) | (0.50) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
65.77% | 63.19% | 85.99% | 86.87% | |
Intangible Assets out of Total Assets |
0.49 | 0.50 | 0.52 | 0.54 | |
Share Based Compensation of Revenue |
4.16% | 3.59% | 6.74% | 16.66% | |
Graham Net Nets |
(0.02) | (0.02) | (0.04) | (0.08) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(3.38%) | (5.39%) | (7.11%) | (11.64%) | |
Free Cash Flow Yield |
1.56% | 0.32% | (0.22%) | (0.28%) | |
Revenue per Share |
0.91 | 1.01 | 0.89 | 0.88 | |
Operating CF per Share |
0.31 | (0.12) | (0.05) | 0.01 | |
Capex per Share |
(0.05) | (0.03) | (0.05) | (0.03) | |
Free Cash Flow per Share |
0.26 | (0.16) | (0.10) | (0.02) | |
Cash per Share |
0.73 | 0.59 | 0.47 | 0.38 | |
Shareholders Equity per Share |
2.61 | 2.65 | 2.38 | 2.20 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.61 | 2.65 | 2.38 | 2.20 | |
Free Cash Flow |
1.15 | (0.68) | (0.43) | (0.11) | |
Working Capital |
(0.08) | 0.17 | (0.53) | (1.30) | |
Capital Expenditures |
(0.21) | (0.15) | (0.20) | (0.15) | |
Net Current Asset Value |
(1.05) | (0.69) | (1.28) | (2.01) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.05 | 0.03 | 0.05 | 0.04 | |
Net Profit Margin |
(9.24%) | (4.81%) | (30.13%) | (27.52%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
2.04 | 2.28 | 2.19 | 1.66 | |
Average Payables |
0.35 | 0.30 | 0.43 | 0.43 | |
Average Inventory |
0.10 | 0.14 | 0.12 | 0.14 | |
Average Assets |
18.51 | 17.94 | 17.21 | 16.40 | |
Average Common Equity |
10.94 | 11.01 | 10.41 | 10.68 |
Columns are period end dates